Cite
Montenegro RC, Howarth A, Ceroni A, et al. Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib. Oncotarget. 2020;11(5):535-549doi: 10.18632/oncotarget.27462.
Montenegro, R. C., Howarth, A., Ceroni, A., Fedele, V., Farran, B., Mesquita, F. P., Frejno, M., Berger, B. T., Heinzlmeir, S., Sailem, H. Z., Tesch, R., Ebner, D., Knapp, S., Burbano, R., Kuster, B., & Müller, S. (2020). Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib. Oncotarget, 11(5), 535-549. https://doi.org/10.18632/oncotarget.27462
Montenegro, Raquel Carvalho, et al. "Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib." Oncotarget vol. 11,5 (2020): 535-549. doi: https://doi.org/10.18632/oncotarget.27462
Montenegro RC, Howarth A, Ceroni A, Fedele V, Farran B, Mesquita FP, Frejno M, Berger BT, Heinzlmeir S, Sailem HZ, Tesch R, Ebner D, Knapp S, Burbano R, Kuster B, Müller S. Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib. Oncotarget. 2020 Feb 04;11(5):535-549. doi: 10.18632/oncotarget.27462. eCollection 2020 Feb 04. PMID: 32082487; PMCID: PMC7007292.
Copy
Download .nbib